Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1988 1
1989 3
1990 1
1991 2
1992 2
1993 1
1994 7
1995 6
1996 1
1997 2
1999 4
2000 4
2001 4
2002 1
2003 2
2004 2
2005 3
2006 1
2007 3
2008 1
2009 1
2010 7
2011 5
2012 3
2013 5
2014 3
2015 1
2017 2
2018 2
2019 6
2020 8
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Breast Ductal Carcinoma In Situ, Comedo Type"
Page 1
Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
[No authors listed] [No authors listed] Prescrire Int. 2013 Dec;22(144):298-303. Prescrire Int. 2013. PMID: 24600734 Review.
Ductal carcinoma in situ develops in the milk ducts without invading the surrounding connective tissue. ...Screening mammography has increased the number of women diagnosed with early-stage ductal carcinoma in situ. What is the best manag …
Ductal carcinoma in situ develops in the milk ducts without invading the surrounding connective tissue. ...Screening ma …
The management of ductal carcinoma in situ of the breast.
Skinner KA, Silverstein MJ. Skinner KA, et al. Endocr Relat Cancer. 2001 Mar;8(1):33-45. doi: 10.1677/erc.0.0080033. Endocr Relat Cancer. 2001. PMID: 11350725 Review.
Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous group of lesions with diverse malignant potential. ...When all patients with ductal carcinoma in situ are considered, the overall mortality from breast cancer …
Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous group of lesions with diverse malignant potenti …
Sentinel node biopsy in ductal carcinoma in situ of the breast: Never justified?
Sorrentino L, Sartani A, Bossi D, Amadori R, Nebuloni M, Truffi M, Bonzini M, Riggio E, Foschi D, Corsi F. Sorrentino L, et al. Breast J. 2018 May;24(3):325-333. doi: 10.1111/tbj.12928. Epub 2017 Oct 11. Breast J. 2018. PMID: 29024241 Free article.
Sentinel lymph node biopsy for ductal carcinoma in situ (DCIS) of the breast is not standard of care. ...Lymph node biopsy was positive in 13 (7.4%) patients, with 8 (61.5%) macrometastases and 5 (38.5%) micrometastases. In these patients, Breast …
Sentinel lymph node biopsy for ductal carcinoma in situ (DCIS) of the breast is not standard of care. ...Lymph n …
Evaluation and management of high risk and premalignant lesions of the breast.
Page DL, Jensen RA. Page DL, et al. World J Surg. 1994 Jan-Feb;18(1):32-8. doi: 10.1007/BF00348189. World J Surg. 1994. PMID: 8197774 Review.
Low replacement doses of conjugated estrogen after the menopause do not further elevate risk beyond that identified by histologic patterns. Non-comedo ductal carcinoma in situ may be considered a true precursor lesion; however, it differs significantly …
Low replacement doses of conjugated estrogen after the menopause do not further elevate risk beyond that identified by histologic patterns. …
The need for epidemiologic studies of in-situ carcinoma of the breast.
Millikan R, Dressler L, Geradts J, Graham M. Millikan R, et al. Breast Cancer Res Treat. 1995 Jul;35(1):65-77. doi: 10.1007/BF00694747. Breast Cancer Res Treat. 1995. PMID: 7612906 Review.
The purpose of this paper is to present background information on carcinoma in situ (CIS) of the breast and to provide a theoretical framework for planning epidemiologic studies which may further our understanding of breast cancer. ...Cohort studies (a …
The purpose of this paper is to present background information on carcinoma in situ (CIS) of the breast and to provide …
Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ.
Toss M, Miligy I, Gorringe K, Mittal K, Aneja R, Ellis I, Green A, Rakha E. Toss M, et al. J Clin Pathol. 2020 Feb;73(2):76-82. doi: 10.1136/jclinpath-2019-205939. Epub 2019 Aug 23. J Clin Pathol. 2020. PMID: 31444238
AIMS: Cathepsin V (CTSV/CTSL2) is a lysosomal cysteine proteinase and plays a role in extracellular matrix degradation. It is associated with poor prognosis in invasive breast cancer (IBC), but its role in breast ductal carcinoma in si …
AIMS: Cathepsin V (CTSV/CTSL2) is a lysosomal cysteine proteinase and plays a role in extracellular matrix degradation. It is associated wit …
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R. van de Vijver MJ, et al. N Engl J Med. 1988 Nov 10;319(19):1239-45. doi: 10.1056/NEJM198811103191902. N Engl J Med. 1988. PMID: 2903446
Amplification of the neu proto-oncogene in breast cancer has been reported to correlate with the presence of lymph-node metastases and with a poor prognosis. ...These 19 were all of the large-cell, comedo growth type. None of 16 ductal carcinomas in …
Amplification of the neu proto-oncogene in breast cancer has been reported to correlate with the presence of lymph-node metastases an …
Predictors of microinvasion and its prognostic role in ductal carcinoma in situ.
Sue GR, Lannin DR, Killelea B, Chagpar AB. Sue GR, et al. Am J Surg. 2013 Oct;206(4):478-81. doi: 10.1016/j.amjsurg.2013.01.039. Epub 2013 Jun 19. Am J Surg. 2013. PMID: 23791403
BACKGROUND: We sought to determine factors predicting microinvasion and the prognostic role it plays in patients with ductal carcinoma in situ (DCIS). ...CONCLUSIONS: Microinvasion was associated with more extensive DCIS, higher grade, comedo …
BACKGROUND: We sought to determine factors predicting microinvasion and the prognostic role it plays in patients with ducta …
Clinicopathologic implications of EpCAM and Sox2 expression in breast cancer.
Abd El-Maqsoud NM, Abd El-Rehim DM. Abd El-Maqsoud NM, et al. Clin Breast Cancer. 2014 Feb;14(1):e1-9. doi: 10.1016/j.clbc.2013.09.006. Epub 2013 Sep 27. Clin Breast Cancer. 2014. PMID: 24201161
BACKGROUND: The purpose of this study was to investigate the clinicopathologic significance of EpCAM and Sox2 expression in breast cancer and to study their correlation during breast cancer progression. PATIENTS AND METHODS: EpCAm and Sox2 expression were assessed u …
BACKGROUND: The purpose of this study was to investigate the clinicopathologic significance of EpCAM and Sox2 expression in breast ca …
An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast.
Kim S, Kim J, Park HS, Kim HY, Lee K, Lee J, Lee H, Kim JY, Kim SI, Cho YU, Park BW. Kim S, et al. Yonsei Med J. 2019 Nov;60(11):1028-1035. doi: 10.3349/ymj.2019.60.11.1028. Yonsei Med J. 2019. PMID: 31637884 Free PMC article.
PURPOSE: To validate and update a nomogram for predicting ductal carcinoma in situ (DCIS) upstaging in preoperative biopsy. ...An updated version of the nomogram appears to provide more accurate information for predicting preoperative DCIS upsta …
PURPOSE: To validate and update a nomogram for predicting ductal carcinoma in situ (DCIS) upstaging in preoperat …
88 results